Veterinary Hospitals Market Segment Overview, Analysis and Forecast to 2032

FMI just issued an industry analysis study on the Veterinary Hospitals Market. According to their results, global Veterinary Hospital sales will reach roughly US$ 74.9 billion in 2022, with a 6.2% expected market growth rate between 2022 and 2032, which is much higher than the historical average.

From 2022 to 2032, private veterinary hospital applications are predicted to generate the most revenue, with a potential absolute dollar opportunity of around US$ 39.9 billion.

The growing demand for meat and milk products, as well as the growing trend of pet ownership, have fueled the growth of the Veterinary Hospitals Market. Over 98 million dogs are kept as pets in the United States alone, with pets residing in approximately 68% of American households. Furthermore, pet ownership has surged by 56% in the United States since 1988.

Pets require veterinarian care not only for emergency situations, but also for immunisations, neutering, and other treatments. This spike in pet culture has led in an increase in global demand for veterinary facilities.

Aside from the pet population, the global cow population has increased significantly in the recent decade due to increased demand for animal products worldwide. Population growth, changes in lifestyle and diet, and an increase in demand for veterinary services have all contributed to the market's expansion.

Worldwide, veterinarians have implemented additional safety precautions that have impacted their care for both sick and healthy pets, resulting in accusations of delays and extended wait periods.

Key Players:

  • CVS Group PLC
  • Greencross Vet
  • Ethos Veterinary Health
  • Pets At Home Group PLC
  • Mars Incorporated
  • Animal Hospital
  • All Pets Animal Hospital
  • Cahaba Valley Animal Clinic
  • Blaine Central Veterinary Clinic
  • Belltowne Veterinary Center

Browse Detail Summary@ https://www.futuremarketinsights.com/reports/veterinary-hospitals-market

Market Segments Covered In Veterinary Hospitals Industry Analysis

By Product Type:

  • Surgery
  • Medicine
  • Consultation

By Animal Type:

  • Companion Animals
  • Farm Animals

By Application:

  • Public
  • Private
  • Others

Comments

Post a Comment

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Image
According to industry predictions, the global Handheld Ultrasound Scanners Market Demand will increase at a CAGR of 9.1% from 2022 to 2032, reaching a value of US$ 472.1 million by the end of 2022. By 2032, sales are estimated to exceed a valuation of roughly US$ 1.1 billion. With an expected 83.6% market share in 2021, the wired modality now leads the sector. Because they connect to Bluetooth or Wi-Fi devices such as mobile phones or tablets, Handheld Ultrasound Scanners are gaining appeal among both medical professionals and non-radiologists. These devices improve networking systems and ease picture transfer to medical facilities. Global Handheld Ultrasound Scanners Market: Dynamics         Technological advancements in medical imaging devices, increased use of Handheld Ultrasound Scanners among non-radiologists, benefits from international trade agreements, increased importing of imaging diagnostics systems, increased use of Handheld Ultrasound Scanners in emergency medical service
Read more

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

Antidiabetics Market to reach US$ 223 billion by 2032, growing at a 9.6% CAGR from 2022 to 2032 | Future Market Insights, Inc.

Image
The global Antidiabetics Market is expected to earn US$ 223 billion while expanding at a CAGR of 9.6% during the forecast period. The rising prevalence of diabetes worldwide can be attributed to the market's expansion. The ageing baby boomer population is another factor driving the market during the forecast period. According to the International Diabetes Federation, the global diabetes incidence will increase from 366 million in 2011 to 552 million by 2030. During the forecast period, the industry is expected to benefit from a significant increase in the number of diabetic patients. Furthermore, new product development is expected to benefit the market in the near future. For example, Novo Nordisk, a Danish pharmaceutical company, announced the launch of oral semaglutide for the treatment of Type 2 diabetes in India in January 2022. Furthermore, the development of advanced pumps based on smart technologies like AI and ML is expected to open up a slew of new doors. For exampl
Read more